Li Zhang - Concepedia

Author

Li Zhang

Shanghai University of Traditional Chinese Medicine ORCID

Also Known As

L Zhang, L. Zhang, LI ZHANG, Li Rita Zhang, Li ZHANG, Li Zhang, Xiao-xi Zeng, Yongbin Zeng, Zhang, L.R., Zhang, Li

211

Publications

4.2K

Citations

H-Index

162

Concepts

All Affiliations

Shanghai University of Traditional Chinese Medicine Longhua Hospital Shanghai University of Traditional Chinese Medicine Shanghai Municipal Education Commission Chongqing Medical University

About

Li Zhang is an author at Shanghai University of Traditional Chinese Medicine specializing in medicine, liver physiology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	39	1.9K
2	Health Sciences	13	15	605
3	Engineering	3	3	60
4	Natural Sciences	1	1	42
5	Nursing	1	1	29

Li Zhang

Publications

3.5K

Citations

H-Index

Page 1

	Year	Citations
Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways Bing Huang, Zhanghua Chen, Lanlan Geng, Cell InflammationPediatric-onset ColitisMucosal ImmunologyPathogenesisImmunology	2019	290
Cannabis smoking and lung cancer risk: Pooled analysis in the <scp>I</scp>nternational <scp>L</scp>ung <scp>C</scp>ancer <scp>C</scp>onsortium Li Zhang, Hal Morgenstern, Sander Greenland, International Journal of Cancer Substance UseEpidemiology Of CancerLung Cancer RiskCancer Risk FactorsTobacco Control	2014	152
H19 promotes cholestatic liver fibrosis by preventing ZEB1‐mediated inhibition of epithelial cell adhesion molecule Yongfeng Song, Chune Liu, Xia Liu, Hepatology	2017	149
Ursolic acid protects mouse liver against CCl4-induced oxidative stress and inflammation by the MAPK/NF-κB pathway Jie‐Qiong Ma, Jie Ding, Li Zhang, Environmental Toxicology and Pharmacology InflammationAnti-inflammatoryMedicineLiver PhysiologyImmunology	2014	125
Prevalence and risk factors of hepatic steatosis and its impact on liver injury in Chinese patients with chronic hepatitis B infection Junping Shi, Jian‐Gao Fan, Rui Wu, Journal of Gastroenterology and Hepatology	2008	119
Integrative analysis of metabolome and gut microbiota in diet-induced hyperlipidemic rats treated with berberine compounds Meng Li, Xiangbing Shu, Hanchen Xu, Journal of Translational Medicine	2016	117
Lactobacillus plantarum NA136 improves the non-alcoholic fatty liver disease by modulating the AMPK/Nrf2 pathway Zijian Zhao, Chao Wang, Li Zhang, Applied Microbiology and Biotechnology Metabolic SyndromeHepatologyBiochemistryLiver PhysiologyLactobacillus Plantarum Na136	2019	109
RETRACTED: Acetylation of lactate dehydrogenase B drives NAFLD progression by impairing lactate clearance Tongxin Wang, Kai Chen, Weilei Yao, Journal of Hepatology Systems BiologyAldehyde DehydrogenaseBiochemistryCatabolismLactate Clearance	2020	105
BabaoDan attenuates high-fat diet-induced non-alcoholic fatty liver disease via activation of AMPK signaling Dandan Sheng, Shanmin Zhao, Lu Gao, Cell & Bioscience	2019	99
Berberine reducing insulin resistance by up-regulating IRS-2 mRNA expression in nonalcoholic fatty liver disease (NAFLD) rat liver Lianjun Xing, Li Zhang, Tao Liu, European Journal of Pharmacology Insulin ResistanceMetabolic SyndromeBiochemistryLiver PhysiologyPhysiology	2011	88

Page 1